Skip to main content

Table 2 Distribution of MTHFR variants in cases and controls and their association with childhood acute lymphoblastic leukemia in patients from trial ALL-BFM 2000

From: Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population

MTHFR

Cases (n = 443) Number (%)

Controls (n = 379) Number (%)

Odds ratio (95% CI)

P

677 CC/1298 AA

49

(11.1)

45

(11.9)

1.00a

 

677 CT/1298 AA

101

(22.8)

67

(17.7)

1.38 (0.83–2.30)

0.21

677 TT/1298 AA

44

(9.9)

41

(10.8)

0.99 (0.55–1.77)

0.96

677 CC/1298 AC

101

(22.8)

87

(23.0)

1.07 (0.65–1.75)

0.80

677 CT/1298 AC

100

(22.6)

85

(22.4)

1.08 (0.66–1.78)

0.76

677 TT/1298 AC

3

(0.7)

2

(0.5)

1.38 (0.22–8.63)

0.73

677 CC/1298 CC

45

(10.2)

52

(13.7)

0.79 (0.45–1.40)

0.43

677 CT/1298 CC

n.d.

 

n.d.

 

-

-

677 TT/1298 CC

n.d.

 

n.d.

 

-

-

  1. n.d., not detected; CI, confidence interval; areference category